Covered recipient · General Payments record
STEVEN O MARX
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2019–2025
$323,218.33
- Reported across 335 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $22,625.00 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $22,625.00 | 18 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $1,000.00 | 01/15/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1240541760 | CMS |
| Abbott Laboratories | $1,000.00 | 01/15/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1240541817 | CMS |
| Abbott Laboratories | $1,000.00 | 02/20/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1240541824 | CMS |
| Abbott Laboratories | $1,500.00 | 03/20/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1240541831 | CMS |
| Abbott Laboratories | $500.00 | 04/24/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1240541878 | CMS |
| Abbott Laboratories | $1,250.00 | 04/24/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1240541936 | CMS |
| Abbott Laboratories | $1,000.00 | 04/24/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1240541949 | CMS |
| Abbott Laboratories | $1,000.00 | 05/19/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1240541930 | CMS |
| Abbott Laboratories | $1,000.00 | 07/10/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1240542027 | CMS |
| Abbott Laboratories | $500.00 | 07/10/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1240542088 | CMS |
| Abbott Laboratories | $250.00 | 07/24/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1240541981 | CMS |
| Abbott Laboratories | $1,000.00 | 07/24/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1240542029 | CMS |
| Abbott Laboratories | $2,500.00 | 07/24/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1240542097 | CMS |
| Abbott Laboratories | $2,000.00 | 08/25/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1240542036 | CMS |
| Abbott Laboratories | $500.00 | 08/25/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1240542104 | CMS |
| Abbott Laboratories | $2,250.00 | 10/20/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1240542165 | CMS |
| Abbott Laboratories | $4,250.00 | 11/20/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1240542171 | CMS |
| Abbott Laboratories | $125.00 | 12/15/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1240542179 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.